Affordable Access

Access to the full text

Mechanisms of Drug Resistance in Acute Myeloid Leukemia

Authors
  • Bobrova, N. M.1
  • Romanovskaya, T. V.2
  • 1 Alexandrov Republican Scientific and Practical Center of Oncology and Medical Radiology, Minsk, Belarus , Minsk (Belarus)
  • 2 Belarusian State University, Minsk, Belarus , Minsk (Belarus)
Type
Published Article
Journal
Biology Bulletin Reviews
Publisher
Pleiades Publishing
Publication Date
Dec 01, 2021
Volume
11
Issue
Suppl 1
Pages
32–46
Identifiers
DOI: 10.1134/S2079086421070021
Source
Springer Nature
Keywords
Disciplines
  • Article
License
Yellow

Abstract

AbstractAcute myeloid leukemia (AML) is a set of hematological diseases characterized by clonal expansion of immature myeloid precursors. Chemotherapy is one of the main methods of AML treatment. However, the emergence of drug resistance in leukemic cells, which is a serious obstacle to the treatment of the disease, worsens the clinical outcome. To develop competent treatment strategies for AML treatment, it is necessary to understand the essence of the mechanisms of resistance to certain cytostatics and cytotoxic drugs. This review examines various currently known mechanisms underlying drug resistance in leukemic cells at the levels of intracellular molecular pathways and intercellular communication.

Report this publication

Statistics

Seen <100 times